Taking the Path to Clearer Skin: Targeted Treatment Through IL-23 Inhibition for Plaque Psoriasis

home / peers-and-perspective / taking-the-path-to-clearer-skin-targeted-treatment-through-il-23-inhibition-for-plaque-psoriasis

Expert dermatologists discuss the impact of plaque psoriasis on patient quality of life and take a deep dive into inhibitors of interleukin-23 (IL-23), reviewing clinical trial data and real-world data, and providing an overview of how IL-23 inhibitors contribute to a rising standard for psoriasis outcomes.

© 2024 MJH Life Sciences

All rights reserved.